Literature DB >> 26085887

Follicle-stimulating hormone: A potential surrogate marker for androgen deprivation therapy oncological and systemic effects.

Jehonathan H Pinthus1.   

Abstract

Year:  2015        PMID： 26085887      PMCID： PMC4455647          DOI： 10.5489/cuaj.2874

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  6 in total

1.  The endocrine profiles in men with localized and locally advanced prostate cancer treated with radical prostatectomy.

Authors:  Jiri Heracek; Michael Urban; Jana Sachova; Jitka Kuncova; Vaclav Eis; Vaclav Mandys; Richard Hampl; Luboslav Starka
Journal:  Neuro Endocrinol Lett       Date:  2007-02       Impact factor: 0.765

2.  Regulation of gonadotropin subunit gene transcription by gonadotropin-releasing hormone: measurement of primary transcript ribonucleic acids by quantitative reverse transcription-polymerase chain reaction assays.

Authors:  A C Dalkin; L L Burger; K W Aylor; D J Haisenleder; L J Workman; S Cho; J C Marshall
Journal:  Endocrinology       Date:  2001-01       Impact factor: 4.736

3.  Serum follicle-stimulating hormone levels predict time to development of castration-resistant prostate cancer.

Authors:  Dylan Hoare; Thomas A A Skinner; Angela Black; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

4.  GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model.

Authors:  Sarah N Hopmans; Wilhelmina C M Duivenvoorden; Geoff H Werstuck; Laurence Klotz; Jehonathan H Pinthus
Journal:  Urol Oncol       Date:  2014-09-18       Impact factor: 3.498

5.  Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT.

Authors:  Laurence Klotz; Chris O'Callaghan; Keyue Ding; Paul Toren; David Dearnaley; Celestia S Higano; Eric Horwitz; Shawn Malone; Larry Goldenberg; Mary Gospodarowicz; Juanita M Crook
Journal:  J Clin Oncol       Date:  2015-03-02       Impact factor: 44.544

6.  Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases.

Authors:  Ahsan Siraj; Virginie Desestret; Martine Antoine; Gaëlle Fromont; Michel Huerre; Marc Sanson; Philippe Camparo; Christophe Pichon; François Planeix; Julie Gonin; Aurelian Radu; Nicolae Ghinea
Journal:  BMC Cancer       Date:  2013-05-20       Impact factor: 4.430
  6 in total
  1 in total

Review 1.  Systems Oncology: Bridging Pancreatic and Castrate Resistant Prostate Cancer.

Authors:  A Fucic; A Aghajanyan; Z Culig; N Le Novere
Journal:  Pathol Oncol Res       Date:  2018-09-16       Impact factor: 3.201
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.